October 25, 2014 10:38 AM ET


Company Overview of Senex Biotechnology, Inc.

Company Overview

Senex Biotechnology, Inc. engages in discovering and developing therapeutic agents to treat cancer, viral diseases, and age-related diseases. The company offers SNX2 non-cytotoxic molecules compounds that are developed against viral diseases, age-associated diseases, and as add-ons to existing anticancer drug regimens; and SNX9 cyclin-dependent kinase inhibitor pathway inhibitors that are developed for cancer treatment. It offers therapeutic agents to treat cancer and a range of diseases associated with the aging process, such as Alzheimer’s disease, renal disease, atherosclerosis, and arthritis. The company was incorporated in 2002 and is based in Columbia, South Carolina.

715 Sumter Street

Coker Life Science Building

Columbia, SC 29208

United States

Founded in 2002





Key Executives for Senex Biotechnology, Inc.

Chief Executive officer
Scientific Advisor
Scientific Advisor
Scientific Advisor
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Molecular Insight Pharmaceuticals, Inc. United States
Champion Investments, Inc. United States
Online Disruptive Technologies, Inc. United States
Histogen, Inc. United States
GrayBug, LLC United States

Recent Private Companies Transactions

Private Placement
April 17, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Senex Biotechnology, Inc., please visit www.senexbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.